Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis
Clinical trial NCT03996369 · COMPLETED
Trial details
- NCT number
- NCT03996369
- Sponsor
- Arena Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-09-15
- Primary completion
- 2021-12-07
- Enrollment
- 354
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.